Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study
Publication date: 2016 Source:Breast Diseases: A Year Book Quarterly, Volume 27, Issue 1 Author(s): L.J. Solin
Source: Breast Diseases: A Year Book Quarterly - Category: Cancer & Oncology Source Type: research
More News: Breast Carcinoma | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Study